Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ:HKPD) Short Interest Update

Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ:HKPD) saw a large decline in short interest during the month of August. As of August 31st, there was short interest totaling 199,260 shares, a decline of 46.8% from the August 15th total of 374,802 shares. Approximately 1.8% of the company’s stock are short sold. Based on an average daily volume of 109,753 shares, the short-interest ratio is currently 1.8 days.

Wall Street Analyst Weigh In

Separately, Weiss Ratings cut shares of Hong Kong Pharma Digital Technology from a “sell (d)” rating to a “sell (e+)” rating in a research report on Thursday, August 13th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, Hong Kong Pharma Digital Technology currently has a consensus rating of “Sell”.

Hong Kong Pharma Digital Technology Stock Down 9.3%

Hong Kong Pharma Digital Technology stock traded down $0.01 during mid-day trading on Tuesday, reaching $0.11. The company’s stock had a trading volume of 1,693,132 shares, compared to its average volume of 1,360,827. The business has a 50 day moving average price of $0.35 and a 200-day moving average price of $0.49. The company has a debt-to-equity ratio of 0.01, a quick ratio of 3.75 and a current ratio of 3.86. Hong Kong Pharma Digital Technology has a twelve month low of $0.10 and a twelve month high of $1.82.

Hong Kong Pharma Digital Technology (NASDAQ:HKPD) last posted its quarterly earnings results on Friday, August 7th. The company reported ($0.04) earnings per share (EPS) for the quarter. The firm had revenue of $3.15 million for the quarter.

Hong Kong Pharma Digital Technology Company Profile

Hong Kong Pharma is an exempted limited liability company formed under the laws of the Cayman Islands on August 17, 2023. As a holding company with no material operations of its own, Hong Kong Pharma conducts its operations through its wholly owned subsidiaries, Joint Cross Border Logistics Company Limited and V-Alliance Technology Supplies Limited, each a limited liability corporation incorporated in Hong Kong and collectively referred to as HK Subsidiaries. Our business offering consists of two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, primarily conducted through our Hong Kong subsidiary, Joint Cross Border, which we refer to as the “Supply Chain Services” division and (ii) OTC pharmaceutical cross-border procurement and distribution, primarily conducted through our Hong Kong subsidiary, V-Alliance, which we refer to as the “Procurement and Distribution” division.